Clinical evaluation of HB vaccine as a component of combination vaccines.
Kane
M A
MA
Global Programme for Vaccines, WHO, Geneva, Switzerland.
D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D006510:Hepatitis B Antibodies / Q000096:biosynthesis*; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000276:immunology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D017778:Vaccines, Combined / Q000276:immunology
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D017778:Vaccines, Combined